Literature DB >> 1655147

Role of the sigma receptor in the inhibition of [3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells.

C Rogers1, S Lemaire.   

Abstract

1. Rat brain synaptosomes and cultured bovine adrenal chromaffin cells were used to monitor the inhibitory effects of phencyclidine (PCP) and sigma (sigma)-receptor ligands on the uptake of [3H]-noradrenaline ([3H]-NA). 2. A Na(+)-dependent high affinity uptake was observed in synaptosomes (30 degrees C) and chromaffin cells (37 degrees C) with Km of 0.22 and 0.56 microM and Vmax of 2.5 pmol min-1 mg-1 protein and 0.7 pmol min-1 per 10(6) cells, respectively. 3. PCP and haloperidol inhibited the high affinity uptake with IC50 of 0.17 and 0.42 microM, respectively in synaptosomes and 0.24 and 0.47 microM, respectively in adrenal chromaffin cells. 4. A close correlation (r = 0.96) was established between the ability of various PCP and sigma-receptor ligands to inhibit [3H]-NA uptake in both systems: PCP greater than TCP greater than haloperidol greater than 3-(+)-PPP greater than MK-801 greater than or equal to (-)-butaclamol greater than (+)-SKF-10047 greater than DTG. Spiperone and opioid receptor ligands were ineffective at 20 microM. 5. These results indicate that the central and peripheral inhibitory effects of PCP and sigma-receptor ligands on [3H]-NA uptake involves a receptor (sigma 1-like) which is distinct from that (PCP2) recognized for the inhibition of [3H]-dopamine uptake by PCP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655147      PMCID: PMC1908209          DOI: 10.1111/j.1476-5381.1991.tb12352.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Study of a new schizophrenomimetic drug; sernyl.

Authors:  E D LUBY; B D COHEN; G ROSENBAUM; J S GOTTLIEB; R KELLEY
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-03

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

4.  Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter.

Authors:  T Pacholczyk; R D Blakely; S G Amara
Journal:  Nature       Date:  1991-03-28       Impact factor: 49.962

5.  A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.

Authors:  S B Hellewell; W D Bowen
Journal:  Brain Res       Date:  1990-09-17       Impact factor: 3.252

Review 6.  Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders.

Authors:  Y Itzhak; I Stein
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

7.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

8.  Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.

Authors:  P M Beart; R D O'Shea; D T Manallack
Journal:  J Neurochem       Date:  1989-09       Impact factor: 5.372

9.  Presence of sigma and phencyclidine (PCP)-like receptors in membrane preparations of bovine adrenal medulla.

Authors:  C Rogers; D Cécyre; S Lemaire
Journal:  Biochem Pharmacol       Date:  1989-08-01       Impact factor: 5.858

10.  Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.

Authors:  S M Jones; L D Snell; K M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

View more
  5 in total

Review 1.  Sigma-1 receptor chaperones and diseases.

Authors:  Shang-Yi Tsai; Teruo Hayashi; Tomohisa Mori; Tsung-Ping Su
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

Review 2.  The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.

Authors:  Sanna K Janhunen; Heta Svärd; John Talpos; Gaurav Kumar; Thomas Steckler; Niels Plath; Linda Lerdrup; Trine Ruby; Marie Haman; Roger Wyler; Theresa M Ballard
Journal:  Psychopharmacology (Berl)       Date:  2015-06-14       Impact factor: 4.530

3.  Pertussis toxin inhibits noradrenaline accumulation by bovine adrenal medullary chromaffin cells.

Authors:  S J Bunn; K J O'Brien; T L Boyd; D A Powis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

4.  The sigma compounds 1,3-di-o-tolylguanidine and N-allylnormetazocine inhibit agonist-stimulated inositol phospholipid metabolism in bovine adrenal medullary cells.

Authors:  S J Bunn; P J Brent; S R O'Malley
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

5.  The EphA4 receptor regulates dendritic spine remodeling by affecting beta1-integrin signaling pathways.

Authors:  Caroline Bourgin; Keith K Murai; Melanie Richter; Elena B Pasquale
Journal:  J Cell Biol       Date:  2007-09-17       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.